{
    "title": "111_hr2813",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``National Knee and Hip Replacement \nRegistry Act of 2009''.\n\nSEC. 2. ESTABLISHMENT.\n\n    (a) In General.--Not later than 3 years after the date of the \nenactment of this Act, the Secretary of Health and Human Services shall \nestablish within the Agency for Healthcare Research and Quality a \nnational knee and hip replacement registry (referred to in this Act as \nthe ``registry'') for the purpose of identifying predictors (including \npatient co-morbidities, conditions, and characteristics; features of \nthe prostheses; and surgical technique) that may lead to poor outcomes \nin knee and hip replacement surgeries in order to assist health care \nproviders in medical and surgical decision-making, improve patient care \nand outcomes generally, detect poorly performing prostheses and \nsurgical techniques, and reduce the number of knee and hip replacement \nrevision surgeries required nationwide.\n    (b) Policies and Procedures.--Such registry shall be subject to the \npolicies and procedures developed under section 3(a).\n\nSEC. 3. KNEE AND HIP REPLACEMENT REGISTRY POLICIES AND PROCEDURES.\n\n    (a) Policies and Procedures.--Not later than 3 years after the date \nof the enactment of this Act, the Administrator of the Centers for \nMedicare and Medicaid Services, in coordination with the Director of \nthe Agency for Healthcare Research and Quality, shall develop policies \nand procedures for the development and maintenance of the registry \nunder section 2. The policies and procedures shall address--\n            (1) the scope of data collection to be conducted by the \n        registry to conform with the purpose of the registry as defined \n        in section 2;\n            (2) the core data set to be used by the registry;\n            (3) policies to be used by the registry to--\n                    (A) ensure scientific rigor in data collection and \n                analysis;\n                    (B) avoid bias in the analysis of data;\n                    (C) ensure that analysis of the data collected can \n                be generalizable to the population of people getting \n                knee and hip replacements;\n                    (D) protect, to the extent practicable, trade \n                secrets of manufacturers of knee and hip replacement \n                prostheses and related products; and\n                    (E) protect patient privacy; and\n            (4) guidelines for data collection that--\n                    (A) incorporate, to the extent practicable, the \n                recommendations and feedback of stakeholders, \n                including--\n                            (i) orthopedic practitioners and providers, \n                        such as hospitals, surgeons, nurses, and other \n                        practitioners and providers;\n                            (ii) manufacturers of knee and hip \n                        replacement prostheses and related products; \n                        and\n                            (iii) patient and consumer groups;\n                    (B) balance the importance and usefulness of \n                potential findings resulting from the collection of \n                data by the registry with the feasibility and \n                administrative burden on collecting such data;\n                    (C) allow the registry to use, to the extent \n                practicable, data that is collected through existing \n                Federal reporting requirements; and\n                    (D) rely, to the extent practicable, on the \n                voluntary submission of data on both Medicare and non-\n                Medicare patients by practitioners and providers.\n    (b) Interagency Cooperation.--In developing of the policies and \nprocedures under subsection (a), the Administrator of the Centers for \nMedicare and Medicaid Services shall consult with the heads of the \nAgency for Healthcare Research and Quality, the Food and Drug \nAdministration, the National Institutes of Health, and the Office of \nthe National Coordinator for Health Information Technology.\n\nSEC. 4. ACTIVITIES OF THE REGISTRY.\n\n    (a) Data Collection and Storage.--Beginning not later than 5 years \nafter the date of the enactment of this Act, the head of the registry \nshall collect and store data related to knee and hip replacements \n(including information related to prosthetic devices and surgical \nprocedures consistent with the policies and procedures under section \n3(a) in the registry established under subsection (a) of section 2).\n    (b) Data Analysis.--The head of the registry shall conduct data \nanalysis to fulfil the purpose of the registry under section 2.\n    (c) Access to Data.--\n            (1) Provision of data to providers.--At least one time per \n        year, beginning not later than 6 years after the date of \n        enactment of this Act, the head of the registry shall provide \n        data to health care providers to allow them to evaluate their \n        performance, relative to their peers, in--\n                    (A) conducting knee and hip replacement surgeries; \n                and\n                    (B) providing care related to such surgeries.\n            (2) Provision of data to manufacturers.--At least one time \n        per year, beginning not later than 7 years after the date of \n        the enactment of this Act, the head of the registry shall \n        provide data to manufacturers of knee and hip replacement \n        prostheses and related products to allow such manufacturers to \n        evaluate the safety and performance of their products relative \n        to similar products available on the market.\n            (3) Use of registry by researchers.--The head of the \n        registry shall develop a process to allow outside researchers \n        to apply to use individually identifiable data that is \n        contained in the registry to conduct longitudinal studies \n        consistent with the purpose of the registry under section 2.\n    (d) Coordination With FDA, NIH, and Other HHS Entities.--To avoid \nduplication in data collection and analysis, the head of the registry \nshall coordinate activities of the registry with--\n            (1) comparative effectiveness research conducted by--\n                    (A) the Agency for Healthcare Research and Quality;\n                    (B) the National Institutes of Health; and\n                    (C) the Office of the Secretary of Health and Human \n                Services; and\n            (2) postmarket surveillance activities conducted by the \n        Food and Drug Administration.\n    (e) Collection of Registry Information From Federal Departments and \nAgencies.--\n            (1) Requests by the registry.--The head of the registry may \n        request data from Federal departments and agencies if the \n        collection of such data by the entity established under section \n        2 conforms with the policies and procedures under section 3.\n            (2) Agency obligations.--Federal departments and agencies \n        shall provide relevant data to the registry at the request of \n        the head of the registry under paragraph (1).\n    (f) Public Feedback.--Not later than 2 years after beginning to \ncollect data under subsection (a) and at the end of each subsequent 2-\nyear period, in order to enhance the registry's ability to achieve the \npurpose of the registry under section 2 and update policies and \nprocedures under section 3, the head of the registry, in consultation \nwith the Center for Medicare and Medicaid Services, the Food and Drug \nAdministration, the Agency for Healthcare Research and Quality, the \nOffice of the National Coordinator of Health Information Technology, \nand the National Institutes of Health shall seek feedback from--\n            (1) orthopedic providers, such as hospitals, surgeons, \n        nurses, and other practitioners;\n            (2) manufacturers of knee and hip replacement prostheses \n        and related products;\n            (3) patient and consumer groups; and\n            (4) public health experts and epidemiologist.\n    (g) Public Report.--Beginning not later than six years after \nenactment, the head of the registry shall publish and make publically \navailable an annual report that contains--\n            (1) an overview of the data collected by under subsection \n        (a);\n            (2) the findings resulting from any analysis of such data \n        conducted by the registry; and\n            (3) any other information that the head of the registry \n        determines is appropriate.\n\nSEC. 5. SAFETY MONITORING AND REPORTING.\n\n    (a) Safety Monitoring.--The Agency for Healthcare Research and \nQuality and the Food and Drug Administration shall use the data in the \nregistry and any analysis of such data conducted by the registry or by \nother entities to monitor and evaluate the safety of knee and hip \nreplacement procedures and devices.\n    (b) Report.--Not later than 6 years after the date of the enactment \nof this Act and annually thereafter, the Agency for Healthcare Research \nand Quality, in consultation with Food and Drug Administration, shall \nsubmit a report to the Secretary of Health and Human Services and \nCongress containing recommendations on changes in policy and health \ncare provider practices that could enhance the safety of knee and hip \nreplacements.\n\nSEC. 6. DEPARTMENT OF HEALTH AND HUMAN SERVICES COLLECTION OF \n              INFORMATION FROM PROVIDERS AND OTHER ENTITIES.\n\n    (a) Modification of Required Data.--The Secretary of Health and \nHuman Services may modify the information required to be reported under \nadministrative data sets under title XVIII of the Social Security Act \n(42 U.S.C. 1395 et seq.) (including data that is required to be \nsubmitted by Medicare Advantage organizations and quality improvement \norganizations) to the extent the Secretary, in consultation with the \nhead of the registry, determines that the modification would result in \nthe reporting of information that would be useful in carrying out the \npurpose of the registry under section 2.\n    (b) Condition of Participation.--In the case that two consecutive \nreports submitted under section 7(a) conclude that the level of \nprovider participation in the registry is insufficient to achieve the \npurpose of the registry under section 2, the Secretary of Health and \nHuman Services may require providers of services (as defined under \nsection 1861(u) of the Social Security Act (42 U.S.C. 1395x(u))) and \nphysicians and other suppliers (as defined in subsections (r) and (d) \nof section 1861 of the Social Security Act (42 U.S.C. 1395x(r) and \n(d)), respectively) to report relevant information directly to the \nregistry as a condition of participation in the Medicare program under \nsection 1866 and 1842(h) of the Social Security Act (42 U.S.C. 1395cc \nand 42 U.S.C. 1395u(h)), respectively.\n\nSEC. 7. OVERSIGHT OF THE REGISTRY.\n\n    (a) In General.--Not later than 1 year after the date the registry \nbegins collecting data under section 4(a) and the end of each \nsubsequent 2-year period, the Comptroller General of the United States \nshall submit to Congress a report on the progress of the registry in \nachieving the purposes of the registry under section 2.\n    (b) Information on Provider Participation.--The report under \nsubsection (a) shall include information on the number of providers \nparticipating in the registry and an analysis of whether that level of \nprovider participation is sufficient to achieve the purposes of the \nregistry under section 2.\n\nSEC. 8. AUTHORIZATION OF APPROPRIATIONS.\n\n    There is authorized to be appropriated to carry out this Act, such \nsums as are necessary for fiscal years 2010 through 2019."
}